>> 全站文章索引 >> 第38页:
  • Safety profile of orlistat results of a prescription-event monitoring study - [Acharya NV, Wilton LV, Shakir SA.]
  • Neuropsychiatric and Cognitive Changes after Surgery for Primary Hyperparathyroidism - [Dotzenrath CM, Kaetsch AK, Pfingsten H, Cupisti K, Weyerbrock N, Vossough A, Verde PE, Ohmann C.]
  • Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age - [Shigeru Morishita 1 2 *, Seizaburo Arita 2 AD:1Depression Prevention Medical Center, Kyoto Jujo Hospital, Kyoto, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
  • Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression - [Shigeru Morishita 1 *, Seizaburo Arita 2 AD:1Department of Psychiatry, Kawasaki Medical School, Kurashiki, Okayama, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
  • Induction of mania in depression by paroxetine - [Shigeru Morishita 1 *, Seizaburo Arita 2 AD:1Department of Psychiatry, Kawasaki Medical School, Kurashiki, Okayama, Japan2Department of Mathematics, Kansai Medical School, Hirakata, Osaka, Japan]
  • Depression, Night Terrors, and Insomnia Associated With Long-Term Intrathecal Clonidine Therapy - [Bevacqua BK, Fattouh M, Backonja M.]
  • The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs - [Y-K Kim1, I-B Suh2, H Kim1, C-S Han1, C-S Lim2, S-H Choi3 and J Licinio4]
  • Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice.A retrospective analysis of data from Norwegian primary pharmacies - [Molden E, Garcia BH, Braathen P, Eggen AE]
  • Personality and the Subjective Effects of Acute Amphetamine in Healthy Volunteers - [Tara L White1, David C Lott2,3 and Harriet de Wit2]
  • The Antidepressant Clomipramine Regulates Cortisol Intracellular Concentrations and Glucocorticoid Receptor Expression in Fibroblasts and Rat Primary Neurones - [Carmine M Pariante1, Abdul Hye2, Ritchie Williamson2, Andrew Makoff1, Simon Lovestone2 and Robert W Kerwin1]
  • Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue - [Javier Angulo, Concepción Peiró, Carlos F Sanchez-Ferrer, Sonia Gabancho, Pedro Cuevas, Sandeep Gupta, I?igo Sáenz de Tejada]
  • Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment - [Rebeca Martínez-Turrillas, Joaquín Del Río and Diana Frechi]
  • [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain - [Cristiana Griffante1, Renzo Carletti1, Filippo Andreetta1 and Mauro Corsi1]
  • Functional consequences of perinatal exposure to3,4-methylenedioxymethamphetamine in rat brain - [Paul A T Kelly, Isobel M Ritchie, Linda Quate, Douglas E McBean, Henry J Olverman]
  • Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps - [Peng Wei, Glenn W. Kaatz and Robert J. Kerns]
  • Molecular genetics of bipolar disorder and depression - [Kato T.]
  • Medication treatments for panic disorder and social phobia - [Murray B. Stein, M.D. * AD: Department of Psychiatry, University of California, San Diego, La Jolla, California]
  • Economic evaluation of paroxetine and imipramine in depressed outpatients. - [Melton ST, Kirkwood CK, Farrar TW, Brink DD, Carroll NV]
  • Resolution of paroxetine precursor using different lipases: Influence of the reaction conditions on the enantioselectivity of lipases - [Gloria Fernández-Lorente, José M. Palomo, Cesar Mateo, José M. Guisan and Roberto Fernandez-Lafuente]
  • Risperidone in the treatment of psychotic depression - [Makiko Goto, Reiji Yoshimura, Shingo Kakihara, Koji Shinkai, Yasuhisa Yamada, Kyoko Kaji, Nobuhisa Ueda and Jun Nakamura]
  • A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March - [G.F. Arag?o, L.M.V. Carneiro, A.P.F. Junior, L.C. Vieira, P.N. Bandeira, T.L.G. Lemos and G.S. de B. Viana]
  • Subliminal affective priming in clinical depression and comorbid anxiety A longitudinal investigation - [Dannlowski U, Kersting A, Lalee-Mentzel J, Donges US, Arolt V, Suslow T.]
  • THE DISCOVERY OF FLUOXETINE HYDROCHLORIDE (PROZAC) - [David T. Wong, Kenneth W. Perry & Frank P. Bymaster about the authors]
  • Assessing the clinical utility of agoraphobia in the context of panic disorder - [Schmidt NB, Cromer KR.]
  • Assessing the clinical utility of agoraphobia in the context of panic disorder - [Schmidt NB, Cromer KR.]
  • The effect of paroxetine on 5-HT(2A) receptors in depression: An [18F]setoperone PET imaging study - [Jeffrey H Meyer, Shitij Kapur, Beata Eisfeld, Gregory M Brown, et al]
  • Treatment ofdepressionin patients with breast cancer:a comparison between paroxetine and amitriptyline - [G. Pezzella, R. Moslinger-Gehmayr, A. Contu]
  • Treatment of bereavement-related depression and traumatic grief - [Paula L. Hensley]
  • HIV-assoziierte Tumore - [A. Potthoff1 und N. H. Brockmeyer]
  • Affective symptoms and cognitive functions in the acute phase of Graves’ thyrotoxicosis - [Vogel A, Elberling TV, H?rding M, Dock J, Rasmussen AK, Feldt-Rasmussen U, Perrild H, Waldemar G.]
  • Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization - [Michihiko Iijima and Shigeyuki Chaki]
  • The Effect of Tryptophan on Social Interaction in Everyday Life: A Placebo-Controlled Study - [DS Moskowitz1 Ph.D, Gilbert Pinard2 MD, David C Zuroff1 Ph.D, Lawrence Annable2 BSc, Dip Stat and Simon N Young2 Ph.D]
  • Digitalis intoxication induced by paroxetine co-administration - [Norio Yasui-Furukori, Sunao Kaneko]
  • Blood–brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls - [Manfred Uhr, Markus T. Grauer, Alexander Yassouridis and Martin Ebinger]
  • First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression - [F Konig, C v Hippel, T Petersdorff, M Neuhoffer-Weiss, et al.]
  • Pharmacogenetics and adverse drug reactions - [Urs A Meyer]
  • Review of 1H magnetic resonance spectroscopy findings in major depressive disorder-A meta-analysis - [Yildiz-Yesiloglu A, Ankerst DP.]
  • Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment - [E. Poulet, J. Brunelin, C. Boeuve, J. Lerond, T. D'Amato, J. Dalery and M. Saoud]
  • Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa - [Agneta Ekman, Charlotta Sundblad-Elverfors, Mikael Landén, Tomas Eriksson and Elias Eriksson]
  • Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients - [F Graziano1, R Bisonni2, V Catalano3, R Silva2, S Rovidati4, E Mencarini4, B Ferraro4, F Canestrari4, A M Baldelli3, A De Gaetano5, P Giordani3, E Testa1 and V Lai1]
  • Questions about SSRI antidepressant drug regulation - [Alastair Hay]
  • The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression - [Robert L. Findling, Nora K. McNamara, Robert J. Stansbrey, Norah C. Feeny, Christopher M. Young, Franco V. Peric, Eric A. Youngstrom]
  • Difficult people getting along - [Larry Greenbaum]
  • Regarding Pooh / The authors respond / Editors' note - [Julie Downs, Leslie Blumenberg, JoAnn Schuh, Stephen Black, et al]
  • Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze - [Venessa Beijamini and Roberto Andreatini]
  • Inhibition of vesicular uptake of monoamines by hyperforin - [Netta Roz, Yehuda Mazur, Amiram Hirshfeld and Moshe Rehavi]
  • Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers - [Ellen R.A. de Bruijn, Bernard G.C. Sabbe, Wouter Hulstijn, Gé S.F. Ruigt and Robbert J. Verkes]
  • The immune system and happiness - [Barak Y.]
  • How nurses in a stroke rehabilitation unit attempt to meet the psychological needs of patients who become depressed following a stroke - [Bennett, Beverley B.]
  • New approaches in managing bipolar depression - [Keck PE, McElroy SL]
  • The physiological and pathophysiological roles of neuronal histamine - [Yanai K, Tashiro M.]
  • Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors - [Cheryl L. Barton, Peter H. Hutson * Merck Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Harlow Essex, U.K.]
  • Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice - [Martine Hasco?t, Michel Bourin, Marie Claude Colombel, Alexandra J. Fiocco and Glen B. Baker]
  • Cell Proliferation is Influenced by Bulbectomy and Normalized by Imipramine Treatment in a Region-Specific Manner - [Gerburg Keilhoff1, Axel Becker2, Gisela Grecksch2, Hans-Gert Bernstein3 and Gerald Wolf1]
  • Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats - [Danusa Dias Soares, Francesca Fernandez, Sylvie Aguerre, Aline Foury, Pierre Mormède and Francis Chaouloff]
  • Concise synthesis of trans- and cis-3,4-disubstituted piperidines based on regio- and stereoselective allylation of cyclopentenyl esters - [Junji Igarashi, Hiroyuki Ishiwata and Yuichi Kobayashi]
  • Critical Prenatal and Postnatal Periods for Persistent Effects of Dexamethasone on Serotonergic and Dopaminergic Systems - [Theodore A Slotkin1, Marisa L Kreider1, Charlotte A Tate1 and Frederic J Seidler1]
  • Have drug companies hyped social anxiety disorder to increase sales? - [David Healy, David V Sheehan]
  • Warnings Added to Two Antidepressants - [Anonymous]
  • Evaluating the tolerability of newer antidepressants - [Dewan MJ, Anand VS.]
  • Evaluating the Tolerability of the Newer Antidepressants - [Dewan MJ, Anand VS.]
  • Centrally active nonhormonal hot flash therapies - [Loprinzi CL, Stearns V, Barton D.]
  • Centrally active nonhormonal hot flash therapies - [Charles Loprinzi and Vered Stearns]
  • Effects of Standardized Extracts of St. John’s Wort on the Single-Unit Activity of Serotonergic Dorsal Raphe Neurons in Awake Cats: Comparisons with Fluoxetine and Sertraline - [Steven T Szabo1 BSc and Pierre Blier2 MD, Ph.D]
  • In Vivo Measurement of the Vesicular Monoamine Transporter in Schizophrenia - [Stephan F Taylor1 MD, Robert A Koeppe2 Ph.D, Rajiv Tandon1 MD, Jon-Kar Zubieta1,4 MD, Ph.D and Kirk A Frey2,3,4 MD, Ph.D]
  • Etiologic Factors of Chronic Constipation—Review of the Scientific Evidence - [Leung FW]
  • A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action - [E C Gunther1, D J Stone1,2, J M Rothberg1 and R W Gerwien1]
  • Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response - [J Kirchheiner1, K Nickchen1, M Bauer2, M-L Wong3, J Licinio3, I Roots1 and J Brockm?ller4]
  • Long term therapy of generalized anxiety disorder - [Frédéric Rouillon]
  • Gender related disabilities in panic disorder - [G. Sachs, M. Amering, P. Berger, H. Katschnig]
  • Are gender differences important for the clinical effects of antidepressants? - [Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, The Danish University Antidepressant Group]
  • Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms - [Moretti R, Torre P, Antonello RM, Cazzato G, Bava A]
  • Neonatal paroxetine withdrawal syndrome. - [Stiskal JA, Kulin N, Koren G, Ho T, Ito S]
  • Role of Norepinephrine in the Pathophysiology and the treatment of mood disorders - [Ressler KJ, Nemeroff CB.]
  • Medicaid Coverage of Newer Psychotropic Medication - [Meenakshi Venkataraman]
  • Targets for the Development of Novel Therapeutics for Bipolar Disorder - [Zarate CA, Singh J, Manji HK.]
  • Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol - [Sati Mazumdar, Patricia R. Houck, Kenneth S. Liu, Benoit H. Mulsant, Bruce G. Pol1ock, Mary Amanda Dew and Charles F. Reynolds III]
  • Posttraumatic stress disorder acquisition, recognition, course, and treatment - [Davidson JR, Stein DJ, Shalev AY, Yehuda R.]
  • Posttraumatic stress disorder: acquisition, recognition, course, and treatment. - [Davidson JR, Stein DJ, Shalev AY, Yehuda R]
  • Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI) - [He Juan, Zhou Zhiling and Li Huande]
  • A Review of its Therapeutic Potential in the Treatment of Depression Associated with Physical Illness - [Cheer SM, Goa KL.]
  • Reduced Density of Platelet-Binding Sites for [3H]Paroxetine in Remitted Bulimic Women - [Howard Steiger1,2,3, Jodie Richardson1,2, Mimi Israel1,2,3, N M K Ng Ying Kin2,3, Kenneth Bruce1,2,3, Sandra Mansour1,2 and Anne Marie Parent1,2]
  • A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment - [J Kirchheiner1, K Nickchen2, J Sasse3, M Bauer3, I Roots2 and J Brockm?ller4]
  • Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? - [Linda Franchini, David Rossini, Fanny Bongiorno, Chiara Spagnolo, Enrico Smeraldi and Raffaella Zanardi]
  • Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction - [H G Nurnberg1, M Fava2, A J Gelenberg3, P L Hensley1 and S Paine1]
  • Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration - [Akira Kugaya, Nicholas M Seneca, Peter J Snyder, Stephen A Williams, Robert T Malison, Ronald M Baldwin, John P]
  • The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test - [H. R. Sumnall, E. O'Shea, C. A. Marsden and J. C. Cole]
  • Changes in anxiety sensitivity with pharmacotherapy for panic disorder - [Naomi M. Simon, Michael W. Otto, Jasper A. J. Smits, D. Colette Nicolaou, Hannah E. Reese and Mark H. Pollack]
  • Fatigue and cancer: causes, prevalence and treatment approaches - [L I Wagner1 and D Cella1]
  • Revamping the Pharmaceutical Industry in Light of GlaxoSmithKline's Settlement - [Benjamin Falit]
  • USE OF HEALTH SERVICES FOR MAJOR DEPRESSIVE AND ANXIETY DISORDERS IN FINLAND - [H?m?l?inen J, Isomets? E, Sihvo S, Pirkola S, Kiviruusu O]
  • USE OF HEALTH SERVICES FOR MAJOR DEPRESSIVE AND ANXIETY DISORDERS IN FINLAND - [H?m?l?inen J, Isomets? E, Sihvo S, Pirkola S, Kiviruusu O.]
  • Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics - [Martin A. Javors, Chamindi Seneviratne, John D. Roache, Nassima Ait-Daoud, Susan E. Bergeson, M. Consuelo Walss-Bass, Fatema Z. Akhtar and Bankole A. Johnson]
  • Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells - [Lynn W. Maines, David A. Antonetti, Ellen B. Wolpert and Charles D. Smith]
  • Enantioselective total and formal syntheses of paroxetine (PAXIL) via phosphine-catalyzed enone α-arylation using arylbismuth(V) reagents: a regiochemical complement to Heck arylation - [Phillip K. Koech and Michael J. Krische]
  • Neurosteroid secretion in panic disorder - [Francesca Brambilla, Giovanni Biggio, Maria Giuseppina Pisu, Laura Bellodi, Giampaolo Perna, Vesna Bogdanovich-Djukic, Robert H. Purdy and Mariangela Serra]
  • Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study - [Stephan A Chalon1, Luc-André Granier1, Fran?ois R Vandenhende1, Peter R Bieck2, Frank P Bymaster2, Melissa J Joliat2, Christine Hirth3 and William Z Potter2]
  • Inflamed brains can trigger the blues, studies suggest - [Gunjan Sinha]
  • L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease - [Roshan Cools1, Simon J G Lewis1, Luke Clark1, Roger A Barker2 and Trevor W Robbins1]
  • Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats - [Jenny C E Owen, Peter S Whitton]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 [38] 39 40
    41 42 43 44 45 46 47 48 49 50